Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey

Abstract

IntroductionRosacea (including facial erythema) has a negative impact on psychological and emotional health. This survey aimed to assess the impact of facial erythema on subconscious perceptions and the initial reactions of others and how this affects attitudes in different settings. The survey also measured the impact of facial erythema on a person’s emotional and psychological wellbeing.MethodsA total of 6831 participants from eight countries completed online computer-assisted web interviewing psychological assessments based on the implicit association test. Traditional questionnaires provided data on the impact of facial erythema and perceptions of people with rosacea from other participants.ResultsFacial erythema was strongly associated with poor health and negative personality traits with participants reporting negative impacts of rosacea emotionally, socially and in the workplace. Nearly 80% reported difficulty in controlling facial erythema but those with physician-diagnosed rosacea had significantly improved control versus those with undiagnosed rosacea (39% vs 20%, p < 0.05).ConclusionsPeople with facial erythema have to manage their own psychological barriers to cope with the disease and deal with the prejudice and negative first impressions of others. Formal diagnosis, advice and treatment from a healthcare professional improve rosacea control.FundingGalderma.Electronic supplementary materialThe online version of this article (doi:10.1007/s13555-015-0077-2) contains supplementary material, which is available to authorized users.

Incidence and prevalence of rosacea: a systematic review and meta-analysis

“…Dirschka et al . used a similar screening method and represented eight countries, giving percentages of self‐reported rosacea (Germany 9%, U.K. 15%, Ireland 15%, Sweden 9%, Denmark 10%, France 15%, Italy 12%, Mexico 8%) and percentages with reported physician‐diagnosed rosacea (Germany 1%, U.K. 2%, Ireland 1%, Sweden 1%, Denmark 1%, France 3%, Italy 1%, Mexico 1%) . Again this shows a conspicuous difference.…”

Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36‐week extension of the ATTRACT randomized study

“…Following the onset of the disease, patients with rosacea will experience cycles of relapse and remission of symptoms throughout their lives. Rosacea is known to have a negative impact on quality of life and is associated with depression and social isolation, hampering both social and professional lives . In a recent National Rosacea Society survey of 1675 patients, 68% of patients with mild rosacea reported an adverse impact on their general outlook on life, with this negative impact increasing to 87% and 95% in patients with moderate and severe symptoms, respectively, highlighting that the emotional impact on patients appears to increase as symptoms become more severe…”

Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel

“…The patient burden of rosacea can be significant. [28][29][30][31][32] However, few tools exist to measure the psychosocial burden of rosacea and, like severity scales, many are repurposed from other areas, with a variety used across the literature. 32 Rosa-QoL is the only quality-of-life instrument specific to rosacea.…”